231 related articles for article (PubMed ID: 28414325)
1. Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.
Ding J; Zhou XT; Zou HY; Wu J
Lab Invest; 2017 Jul; 97(7):819-832. PubMed ID: 28414325
[TBL] [Abstract][Full Text] [Related]
2. Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.
Fan YH; Ding J; Nguyen S; Liu XJ; Xu G; Zhou HY; Duan NN; Yang SM; Zern MA; Wu J
Oncogene; 2016 Jan; 35(1):116-24. PubMed ID: 25772244
[TBL] [Abstract][Full Text] [Related]
3. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
Chen X; Lingala S; Khoobyari S; Nolta J; Zern MA; Wu J
J Hepatol; 2011 Oct; 55(4):838-45. PubMed ID: 21334406
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells.
Po A; Citarella A; Catanzaro G; Besharat ZM; Trocchianesi S; Gianno F; Sabato C; Moretti M; De Smaele E; Vacca A; Fiori ME; Ferretti E
Sci Rep; 2020 Aug; 10(1):13988. PubMed ID: 32814794
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
[TBL] [Abstract][Full Text] [Related]
6. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
[TBL] [Abstract][Full Text] [Related]
7. Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway.
Ma S; Liu D; Tan W; Du B; Liu W; Li W; Jiao Y
J Cell Biochem; 2020 Jun; 121(5-6):3256-3265. PubMed ID: 31904145
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer.
Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q
Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122
[TBL] [Abstract][Full Text] [Related]
9. The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance.
Chow AK; Ng L; Lam CS; Wong SK; Wan TM; Cheng NS; Yau TC; Poon RT; Pang RW
PLoS One; 2013; 8(11):e78675. PubMed ID: 24244338
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma.
Ding J; Li HY; Zhang L; Zhou Y; Wu J
Cells; 2021 Jan; 10(1):. PubMed ID: 33440657
[TBL] [Abstract][Full Text] [Related]
11. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
12. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.
Xu Y; Chenna V; Hu C; Sun HX; Khan M; Bai H; Yang XR; Zhu QF; Sun YF; Maitra A; Fan J; Anders RA
Clin Cancer Res; 2012 Mar; 18(5):1291-302. PubMed ID: 21868763
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
Chen Y; Bieber MM; Teng NN
Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
[TBL] [Abstract][Full Text] [Related]
15. Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG.
Zhao H; Li N; Pang Y; Zhao J; Wu X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313950
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling.
Harada K; Ohashi R; Naito K; Kanki K
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354204
[TBL] [Abstract][Full Text] [Related]
17. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.
Zhang Y; Laterra J; Pomper MG
Neoplasia; 2009 Jan; 11(1):96-101. PubMed ID: 19107236
[TBL] [Abstract][Full Text] [Related]
19. Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
Zhang Y; Liu W; He W; Zhang Y; Deng X; Ma Y; Zeng J; Kou B
Int J Oncol; 2016 May; 48(5):2035-42. PubMed ID: 26983576
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma.
Singh RR; Kunkalla K; Qu C; Schlette E; Neelapu SS; Samaniego F; Vega F
Oncogene; 2011 Dec; 30(49):4874-86. PubMed ID: 21625222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
